Keywords: cantab, puts, itself, up, sale, following, disappointing

Cantab Puts Itself Up For Sale?

Article | 15 May 1995

Print This

Following the disappointing results from Phase II clinical trials of LM-CD45, a treatment for kidney transplant being codeveloped with Baxter ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in